Orofacial granulomatosis (OFG) is a rare and heterogeneous clinical condition that presents with chronic swelling of the oral or facial tissues due to granulomatous inflammation. It is histologically characterized by noncaseating giant cell granulomata and epithelioid histiocytes. OFG includes the previously recognized clinical entities of Melkersson-Rosenthal syndrome and cheilitis granulomatosa (Miescher’s cheilitis). A consistently effective medical treatment is not currently available. We describe an adolescent patient with a history of recurrent orofacial swelling preceding gastrointestinal symptoms by several years. He exhibited clinical and histological changes consistent with the diagnosis of OFG. It was resistant to standard therapies such as topical corticosteroids. Thorough history taking and clinical examination suggested Crohn’s disease (CD), and further tests confirmed the diagnosis. The patient improved promptly after initiating oral treatment for CD with mesalazine and prednisolone. We conclude that OFG may be under- or misdiagnosed since the clinical manifestation may be misleading and its course is independent of or even preceding CD. Thus, patients with OFG should be asked about gastrointestinal symptoms consistent with CD. Those with suspicious symptoms should undergo a careful gastrointestinal evaluation, possibly including enteroclysis and complete gastrointestinal endoscopic examination, especially when the patient’s history is conspicuous.

1.
Wiesenfeld D, Ferguson MM, Mitchell DN, MacDonald DG, Scully C, Cochran K, Russell RI: Oro-facial granulomatosis – A clinical and pathological analysis. Q J Med 1985;213:101–113.
2.
Rogers RS 3rd: Granulomatous cheilitis, Melkersson-Rosenthal syndrome, and orofacial granulomatosis. Arch Dermatol 2000;136:1557–1558.
3.
Rees TD: Orofacial granulomatosis and related conditions. Periodontology 2000;21:145–157.
4.
Patton DW, Ferguson MM, Forsyth A, James J: Oro-facial granulomatosis: A possible allergic basis. Br J Oral Maxillofac Surg 1998;23:235–242.
5.
Field EA, Tyldesley WR: Oral Crohn’s disease revisited – A 10-year-review. Br J Oral Maxillofac Surg 1988;27:114–123.
6.
Carr D: Granulomatous cheilitis in Crohn’s disease. Br Med J 1974;iv:636.
7.
Hernandez G, Hernandez F, Lucas M: Miescher’s granulomatous cheilitis: Literature review. J Oral Maxillofac Surg 1986;44:474–478.
8.
Melkersson E: Ett fall av recidiverande facialispares i samband met angioneurotisk ödem. Hygeia 1928;90:737–744.
9.
Rosenthal C: Klinisch-erbbiologischer Beitrag zur Konstitutionspathologie: Gemeinsames Auftreten von (rezidivierender familiärer) Facialislähmung, angioneurotischem Gesichtsödem und Lingua plicata in Arthritismus- Familien. Z Gesamte Neurol Psychiatr 1931;131:475–501.
10.
Miescher G: Über essentielle granulomatöse Makrocheilie (Cheilitis granulomatosa). Dermatologica 1945;91:57–85.
11.
Kolokotronis A, Antoniades D, Trigonidis G, Papanagiotou P: Granulomatous cheilitis: A study of six cases. Oral Dis 1997;3:188–192.
12.
Williams AJK, Wray D, Ferguson A: The clinical entity of orofacial Crohn’s disease. Q J Med 1991;79:451–458.
13.
Scully C, Cochran KM, Russel RI, Ferguson MM, Ghouri MA, Lee FD, MacDonald DG, McIntyre PB: Crohn’s disease of the mouth: An indicator of intestinal involvement. Gut 1982;23:198–201.
14.
Ziem PE, Pfrommer C, Goerdt S, Orfanos CE, Blume-Peytavi U: Melkersson-Rosenthal syndrome in childhood: A challenge in differential diagnosis and treatment. Br J Dermatol 2000;143:860–863.
15.
Dummer W, Lurz C, Jeschke R Meissner N, Rose C, Brocker EB: Granulomatous cheilitis and Crohn’s disease in a 3-year-old boy. Pediatr Dermatol 1999;16:39–42.
16.
Crohn BB, Ginzburg L, Oppenheimer GD: Regional ileitis: A pathologic and clinical entity. JAMA 1932;9a:1323–1328.
17.
McCallum DI, Kinmont PDC: Dermatological manifestations of Crohn’s disease. Br J Dermatol 1968;80:1–8.
18.
Burgdorf W: Cutaneous manifestations of Crohn’s disease. J Am Acad Dermatol 1981;5:689–695.
19.
Pittock S, Drumm B, Fleming P, McDermott M, Imrie C, Flint S, Bourke B: The oral cavity in Crohn’s disease. J Pediatr 2001;138:767–771.
20.
Talbot T, Jewell L, Schloss E, Yakimets W, Thomson AB: Cheilitis antedating Crohn’s disease: Case report and literature update of oral lesions. J Clin Gastroenterol 1984;6:349–354.
21.
Tyldesley WR: Oral Crohn’s disease and related conditions. Br J Oral Surg 1979;17:1–9.
22.
Croft CB, Wilkinson AR: Ulceration of the mouth, pharynx, and larynx in Crohn’s disease of the intestine. Br J Surg 1972;59:249–252.
23.
Basu MK, Asquith P, Thompson RA, Cooke WT: Oral lesions in patients with Crohn’s disease. Gut 1974;15:346.
24.
Frankel DH, Mostofi RS, Loriniz AL: Oral Crohn’s disease: Report of two cases in brothers with metallic dysgeusia and a review of the literature. J Am Acad Dermatol 1985;112:260–268.
25.
Issa MA: Crohn’s disease of the mouth. Br Dent J 1971;130:247–248.
26.
Schiller KFR, Golding PL, Peebles RA, Whitehead R: Crohn’s disease of the mouth and lips. Gut 1971;12:864–865.
27.
Plauth M, Jenss H, Meyle J: Oral manifestations of Crohn’s disease: An analysis of 79 cases. J Clin Gastroenterol 1991;13:29–37.
28.
Lebwohl M, Fleischmajer R, Janowitz H, Present D, Prioleau PG: Metastatic Crohn’s disease. J Am Acad Dermatol 1984;10:33–38.
29.
Shum DT, Guenther L: Metastatic Crohn’s disease: Case report and review of the literature. Arch Dermatol 1990;126:645–648.
30.
Vettraino IM, Merritt DF: Crohn’s disease of the vulva. Am J Dermatopathol 1995;17:410–413.
31.
Samitz MH: Skin complications of ulcerative colitis and Crohn’s disease. Cutis 1973;12:533–536.
32.
Perret CM, Bahmer FA: Extensive necrobiosis in metastatic Crohn’s disease. Dermatologica 1987;175:208–212.
33.
Hornstein OP, Stosiek N, Schönberger A, Meisel-Stosiek M: Klassifikation und klinische Variationsbreite des Melkersson-Rosenthal-Syndroms (MRS). Z Hautkr 1987;62:1453–1466.
34.
Greene RM, Rogers RS 3rd: Melkersson-Rosenthal syndrome: A review of 36 patients. J Am Acad Dermatol 1989;21:1263–1270.
35.
Rogers RS 3rd: Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin 1996;14:371–379.
36.
Cleary KR, Batsakis JG: Orofacial granulomatosis and Crohn’s disease. Ann Otol Rhinol Laryngol 1996;105:166–167.
37.
Sabroe RA, Kennedy CT: Facial granulomatous lymphoedema and syringomyelia. Clin Exp Dermatol 1996;21:72–74.
38.
Young WG, Sauk JJ Jr, Pihlstrom B, Fish AJ: Histopathology and electron microscopy of gingivitis granulomatosa associated with glossitis and cheilitis in a case of Anderson-Fabry disease. Oral Surg Oral Med Oral Pathol 1978;46:540–554.
39.
Harms M, Masouyé I, Saurat JH: Silica granuloma mimicking granulomatous cheilitis. Dermatologica 1990;181:246–247.
40.
Hornstein OP: Melkersson-Rosenthal syndrome: A neuro-mucocutaneous disease of complex origin. Curr Probl Dermatol 1973;5:117–156.
41.
Westermark P, Henriksson TG: Granulomatous inflammation of the vulva and penis – A genital counterpart to cheilitis granulomatosa. Dermatologica 1979;158:269–274.
42.
Hackel H, Hartmann AA, Burg G: Vulvitis granulomatosa and anoperineitis granulomatosa. Dermatologica 1991;182:128–131.
43.
James J, Patton DW, Lewis CJ, Kirkwood EM, Ferguson MM: Oro-facial granulomatosis and clinical atopy. J Oral Med 1986;41:29–30.
44.
Lygidakis C, Trakamarakas C, Ilias A, Vassilopoulos D: Melkersson-Rosenthal syndrome in four generations. Clin Genet 1979;15:189–192.
45.
Sweatman MC, Tasker R, Warner JO, Ferguson MM, Mitchell DN: Oro-facial granulomatosis: Response to elementary diet and provocation by food additives. Clin Allergy 1986;16:331–338.
46.
Oliver AJ, Rich AM, Reade PC, Varigos GA, Radden BG: Monosodium glutamate-related orofacial granulomatosis: Review and case report. Oral Surg Oral Med Oral Pathol 1991;71:560–564.
47.
Pryce DW, King CM: Orofacial granulomatosis associated with delayed hypersensitivity to cobalt. Clin Exp Dermatol 1990;15:384–386.
48.
Morales C, Penarrocha M, Bagan JV, Burches E, Pelaez A: Immunological study of Melkersson-Rosenthal syndrome: Lack of response to food additive challenge. Clin Exp Allergy 1995;25:260–264.
49.
Ivanyi L, Kirby A, Zakrzewska JM: Antibodies to mycobacterial stress protein in patients with orofacial granulomatosis. J Oral Pathol Med 1993;22:320–322.
50.
Gratton CE: Orofacial granulomatosis with positive Kveim test. Clin Exp Dermatol 1988;13:419.
51.
Shehade SA, Foulds IS: Granulomatous cheilitis and a positive Kveim test. Br J Dermatol 1986;115:619–622.
52.
Henry CH: Orofacial granulomatosis: Report of a case with decreased CD4/CD8 ratio. J Oral Maxillofac Surg 1994;52:317–322.
53.
Armstrong DK, Biagioni P, Lamey PJ, Burrows D: Contact hypersensitivity in patients with orofacial granulomatosis. Am J Contact Dermat 1997;8:35–38.
54.
Orofacial granulomatosis (editorial). Lancet 1991;338:20–21.
55.
Worsaae N, Christensen KC, Schiodt M, Reibel J: Melkersson-Rosenthal syndrome and cheilitis granulomatosa: A clinicopathologic study of 33 patients with special reference to their oral lesions. Oral Surg 1982;54:404–413.
56.
Sakuntabhai A, Macleod RI, Lawrence CM: Intralesional steroid injection after nerve block anesthesia in the treatment of orofacial granulomatosis. Arch Dermatol 1993;129:477–480.
57.
Allen CM, Camisa C, Hamzeh S, Stephens L: Cheilitis granulomatosa: Report of six cases and review of the literature. J Am Acad Dermatol 1990;23:444–450.
58.
Grange F, Djilali-Bouzina F, Weiss AM, Polette A, Guillaume JC: Corticosteroid-resistant pyoderma gangrenosum associated with Crohn’s disease: Rapid cure with infliximab. Dermatology 2002;205:278–280.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.